January 30, 2015 9:17 AM ET


Company Overview of Invivis Pharmaceuticals Inc.

Executive Profile

Alexander M. M. Eggermont M.D., Ph.D.

Member of Scientific Committee and Member of The Board of Directors, Invivis Pharmaceuticals Inc.
AgeTotal Calculated CompensationThis person is connected to 3 Board Members in 3 different organizations across 4 different industries.

See Board Relationships


Mr. Alexander M. M. Eggermont, also known as Alex, MD, PhD serves as Client Consultant of NovaRx Corporation. Mr. Eggermont is a Full Professor of Surgical Oncology at Rotterdam's Erasmus University. He serves as Head of the Department of Surgical Oncology of the Erasmus University Medical Center - Daniel den Hoed Cancer Center in Rotterdam, The Netherlands. Mr. Eggermont specializes in preclinical and clinical / translational oncology. He is a specialist in immunotherapy ...

Corporate Headquarters

547 Meadow Road
Bridgewater, New Jersey 08807

United States

Phone: 908-818-9393
Fax: 888-591-1834

Board Members Memberships

Member of Scientific Committee and Member of The Board of Directors


PhD 1987
Erasmus University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Invivis Pharmaceuticals Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.